Literature DB >> 9870905

Metabolism of dietary alpha-linolenic acid vs. eicosapentaenoic acid in rat immune cell phospholipids during endotoxemia.

J D Palombo1, S J DeMichele, P J Boyce, M Noursalehi, R A Forse, B R Bistrian.   

Abstract

Short-term (i.e., 3 d) continuous enteral feeding of diets containing eicosapentaenoic (EPA) and gamma-linolenic (GLA) polyunsaturated fatty acids (PUFA) to endotoxemic rats reduces the levels of arachidonic acid (AA) and linoleic acid (LA) in alveolar macrophage (AM) and liver Kupffer and endothelial (K&amp;E) cell phospholipids with attendant decreases in prostaglandin formation by these cells in vitro. Diets that contain alpha-linolenic acid (LNA) as a substrate for endogenous formation of EPA may not be as effective in facilitating these immune cell modifications given the limited activity of delta6 desaturase. In the present study we compared the effectiveness of an LNA-enriched diet vs. an (EPA + GLA)-enriched diet to displace phospholipid AA from AM and liver K&amp;E cells in vivo in endotoxemic rats fed enterally for 3 or 6 d. We determined the fatty acid composition of AM and K&amp;E cell phospholipids by gas chromatography. We found that AM and K&amp;E cells from rats that had received the EPA + GLA diet for 3 d had significantly (P < 0.001) higher mole percentage of EPA and the GLA metabolite, dihomoGLA, than corresponding cells from rats given the LNA diet or a control diet enriched with LA. Rats given the LNA diet had relatively low levels of stearidonic acid, EPA and other n-3 PUFA, while rats given the LA diet had low levels of GLA and dihomoGLA. We conclude that diets enriched with LNA or LA may not be as effective as those enriched with EPA + GLA for purposes of fostering incorporation of EPA or dihomoGLA into and displacement of AA from macrophage phospholipids under pathophysiologic conditions commonly found in acutely septic patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9870905     DOI: 10.1007/s11745-998-0311-x

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  36 in total

1.  Effects of prostaglandin E1 on oxygen delivery and consumption in patients with the adult respiratory distress syndrome. Results from the prostaglandin E1 multicenter trial. The Prostaglandin E1 Study Group.

Authors:  H J Silverman; G Slotman; R C Bone; R Maunder; T M Hyers; M D Kerstein; J J Ursprung
Journal:  Chest       Date:  1990-08       Impact factor: 9.410

2.  Effect of short-term enteral feeding with eicosapentaenoic and gamma-linolenic acids on alveolar macrophage eicosanoid synthesis and bactericidal function in rats.

Authors:  J D Palombo; S J DeMichele; P J Boyce; E E Lydon; J W Liu; Y S Huang; R A Forse; J P Mizgerd; B R Bistrian
Journal:  Crit Care Med       Date:  1999-09       Impact factor: 7.598

3.  Fatty acid intake and Kupffer cell function: fish oil alters eicosanoid and monokine production to endotoxin stimulation.

Authors:  T R Billiar; P E Bankey; B A Svingen; R D Curran; M A West; R T Holman; R L Simmons; F B Cerra
Journal:  Surgery       Date:  1988-08       Impact factor: 3.982

4.  Effects of prostaglandin E1 in postoperative surgical patients with circulatory deficiency.

Authors:  P L Appel; W C Shoemaker; H B Kram
Journal:  Chest       Date:  1991-04       Impact factor: 9.410

5.  Effects of a fish oil diet on pigs' cardiopulmonary response to bacteremia.

Authors:  M J Murray; B A Svingen; R T Holman; T L Yaksh
Journal:  JPEN J Parenter Enteral Nutr       Date:  1991 Mar-Apr       Impact factor: 4.016

6.  alpha-Linolenic, eicosapentaenoic and docosahexaenoic acids affect lipid metabolism differently in rats.

Authors:  I Ikeda; K Wakamatsu; A Inayoshi; K Imaizumi; M Sugano; K Yazawa
Journal:  J Nutr       Date:  1994-10       Impact factor: 4.798

7.  Organ interactions in sepsis. Host defense and the hepatic-pulmonary macrophage axis.

Authors:  M P Callery; T Kamei; M J Mangino; M W Flye
Journal:  Arch Surg       Date:  1991-01

Review 8.  The pathogenesis of sepsis.

Authors:  R C Bone
Journal:  Ann Intern Med       Date:  1991-09-15       Impact factor: 25.391

9.  Fatty acid composition of lung, macrophage and surfactant phospholipids after short-term enteral feeding with n-3 lipids.

Authors:  J D Palombo; E E Lydon; P L Chen; B R Bistrian; R A Forse
Journal:  Lipids       Date:  1994-09       Impact factor: 1.880

10.  The metabolism of 7,10,13,16,19-docosapentaenoic acid to 4,7,10,13,16,19-docosahexaenoic acid in rat liver is independent of a 4-desaturase.

Authors:  A Voss; M Reinhart; S Sankarappa; H Sprecher
Journal:  J Biol Chem       Date:  1991-10-25       Impact factor: 5.157

View more
  9 in total

1.  Comparison of growth and fatty acid metabolism in rats fed diets containing equal levels of gamma-linolenic acid from high gamma-linolenic acid canola oil or borage oil.

Authors:  J D Palombo; S J DeMichele; J W Liu; B R Bistrian; Y S Huang
Journal:  Lipids       Date:  2000-09       Impact factor: 1.880

2.  Dietary n-3 polyunsaturated fatty acids increase T-lymphocyte phospholipid mass and acyl-CoA binding protein expression.

Authors:  Lauren W Collison; Robert E Collison; Eric J Murphy; Christopher A Jolly
Journal:  Lipids       Date:  2005-01       Impact factor: 1.880

3.  Metabolomics investigation of dietary effects on flesh quality in grass carp (Ctenopharyngodon idellus).

Authors:  Honghao Zhao; Jasmine Chong; Rong Tang; Li Li; Jianguo Xia; Dapeng Li
Journal:  Gigascience       Date:  2018-10-01       Impact factor: 6.524

4.  A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injury.

Authors:  Renee D Stapleton; Thomas R Martin; Noel S Weiss; Joseph J Crowley; Stephanie J Gundel; Avery B Nathens; Saadia R Akhtar; John T Ruzinski; Ellen Caldwell; J Randall Curtis; Daren K Heyland; Timothy R Watkins; Polly E Parsons; Julie M Martin; Mark M Wurfel; Teal S Hallstrand; Kathryn A Sims; Margaret J Neff
Journal:  Crit Care Med       Date:  2011-07       Impact factor: 7.598

5.  Dietary docosahexaenoic acid suppresses inflammation and immunoresponses in contact hypersensitivity reaction in mice.

Authors:  Y I Tomobe; K Morizawa; M Tsuchida; H Hibino; Y Nakano; Y Tanaka
Journal:  Lipids       Date:  2000-01       Impact factor: 1.880

Review 6.  Omega-3 fatty acids in critical illness.

Authors:  Julie M Martin; Renee D Stapleton
Journal:  Nutr Rev       Date:  2010-09       Impact factor: 7.110

7.  Enteral nutrition with eicosapentaenoic acid, γ-linolenic acid and antioxidants in the early treatment of sepsis: results from a multicenter, prospective, randomized, double-blinded, controlled study: the INTERSEPT study.

Authors:  Alessandro Pontes-Arruda; Laércia Ferreira Martins; Samya Maria de Lima; Alexandre Marini Isola; Diogo Toledo; Ederlon Rezende; Marcelo Maia; Gisele Brocco Magnan
Journal:  Crit Care       Date:  2011-06-09       Impact factor: 9.097

Review 8.  Critical advances in septicemia and septic shock.

Authors:  U N Das
Journal:  Crit Care       Date:  2000-09-07       Impact factor: 9.097

9.  Prospective Randomized Trial on Postoperative Administration of Diet Containing Eicosapentaenoic Acid, Docosahexaenoic Acid, Gamma-linolenic Acid, and Antioxidants in Head and Neck Cancer Surgery Patients with Free-flap Reconstruction.

Authors:  Kiyoaki Tsukahara; Ray Motohashi; Hiroki Sato; Minoru Endo; Yuri Ueda; Kazuhiro Nakamura
Journal:  Jpn Clin Med       Date:  2014-10-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.